Rhumbline Advisers »

Pacira Pharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.4M 161k 15.05
2024-06-30 $4.6M 160k 28.61
2024-03-31 $4.4M 150k 29.22
2023-12-31 $5.0M 149k 33.74
2023-09-30 $4.3M 141k 30.68
2023-06-30 $5.6M 140k 40.07
2023-03-31 $5.6M 137k 40.81
2022-12-31 $5.0M 131k 38.61
2022-09-30 $7.0M 131k 53.19
2022-06-30 $7.3M 126k 58.30
2022-03-31 $8.9M 117k 76.32
2021-12-31 $6.6M 110k 60.17
2021-09-30 $6.1M 109k 56.00
2021-06-30 $7.6M 125k 60.68
2021-03-31 $8.8M 126k 70.09
2020-12-31 $7.5M 126k 59.84
2020-09-30 $7.2M 119k 60.12
2020-06-30 $7.1M 136k 52.47
2020-03-31 $4.7M 141k 33.53
2019-12-31 $6.4M 140k 45.30
2019-09-30 $4.9M 128k 38.07
2019-06-30 $2.5M 58k 43.49
2019-03-31 $2.1M 55k 38.06
2018-12-31 $2.4M 55k 43.02
2018-09-30 $1.8M 37k 49.16
2018-06-30 $1.3M 40k 32.06
2018-03-31 $1.2M 39k 31.14
2017-12-31 $1.8M 40k 45.64
2017-09-30 $1.9M 50k 37.55
2017-06-30 $2.3M 49k 47.70
2017-03-31 $2.2M 48k 45.59
2016-12-31 $1.5M 46k 32.30
2016-09-30 $1.5M 44k 34.23
2016-06-30 $1.5M 45k 33.72
2016-03-31 $2.3M 44k 52.97
2015-12-31 $3.3M 43k 76.78
2015-09-30 $1.6M 39k 41.11
2015-06-30 $2.7M 39k 70.72
2015-03-31 $3.5M 40k 88.86
2014-12-31 $3.0M 33k 88.66
2014-09-30 $3.4M 35k 96.92
2014-06-30 $3.2M 35k 91.86
2014-03-31 $2.2M 31k 69.99
2013-12-31 $1.9M 32k 57.48
2013-09-30 $1.4M 29k 48.09
2013-06-30 $835k 29k 29.01
2013-03-31 $628k 22k 28.86
2012-12-31 $413k 24k 17.46
2012-09-30 $304k 18k 17.40
2012-06-30 $240k 15k 16.01